ScoreWhy is Sudarshan Pharma Industries Ltd ?
1
Healthy long term growth as Operating profit has grown by an annual rate 47.89%
2
Positive results in Mar 26
- NET SALES(Q) Highest at Rs 220.92 cr
- PBDIT(Q) Highest at Rs 20.19 cr.
- PBT LESS OI(Q) Highest at Rs 11.57 cr.
3
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 20-May-26 and has generated 5.93% returns since then
- The stocks MACD and Bollinger Band technical factors are also Bullish
4
With ROCE of 10.5, it has a Attractive valuation with a 2.6 Enterprise value to Capital Employed
- Over the past year, while the stock has generated a return of 6.15%, its profits have risen by 36% ; the PEG ratio of the company is 1
5
Market Beating performance in long term as well as near term
- Along with generating 6.15% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sudarshan Pharma should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sudarshan Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sudarshan Pharma
29.55%
0.11
53.60%
Sensex
-11.8%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
28.10%
EBIT Growth (5y)
47.89%
EBIT to Interest (avg)
2.17
Debt to EBITDA (avg)
5.40
Net Debt to Equity (avg)
1.83
Sales to Capital Employed (avg)
1.53
Tax Ratio
23.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.92%
ROCE (avg)
10.59%
ROE (avg)
15.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
35
Industry P/E
36
Price to Book Value
5.64
EV to EBIT
22.33
EV to EBITDA
20.62
EV to Capital Employed
2.64
EV to Sales
1.58
PEG Ratio
1.11
Dividend Yield
NA
ROCE (Latest)
10.83%
ROE (Latest)
15.03%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(Latest six months)
At Rs 395.34 cr has Grown at 28.84%
PAT(Latest six months)
At Rs 16.59 cr has Grown at 30.77%
-4What is not working for the Company
INTEREST(Latest six months)
At Rs 15.74 cr has Grown at 28.81%
Loading Valuation Snapshot...
Here's what is working for Sudarshan Pharma
Net Sales - Latest six months
At Rs 395.34 cr has Grown at 28.84%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 16.59 cr has Grown at 30.77%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Sudarshan Pharma
Interest - Latest six months
At Rs 15.74 cr has Grown at 28.81%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
